Lost password ?
Gulf Pharmaceutical
Expected partial recovery in 2020
- "It will not be an easy task for Julphar to get its profitability back after two years of accumulated net losses. The good news during this year is the fact that the group’s exports to Saudi Arabia ..."
Executive summary
Conflicts of Interest
Pages 36
Language English
Publish on August 24, 2020
€ 500
VAT Exl.
You may also be interested by these reports :
FIND A REPORT
SIMPLE, TO THE POINT IDEA GENERATION
Each company is researched in depth using a structured, robust and transparent process. Valuations are disciplined and dispassionate.
AlphaMena allows you to compare stocks along a wide range of parameters be it by sector, by geography or an array of investment themes.
Our reports include actuarial as well as off balance-sheet data and governance metrics.
Priority is given to idea generation through quick, to the point, answers by means of browsing from one idea to the next.